Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Current Leases (2016 - 2025)

Wave Life Sciences' Current Leases history spans 11 years, with the latest figure at $8.4 million for Q4 2025.

  • For Q4 2025, Current Leases rose 9.47% year-over-year to $8.4 million; the TTM value through Dec 2025 reached $8.4 million, up 9.47%, while the annual FY2025 figure was $8.4 million, 9.47% up from the prior year.
  • Current Leases reached $8.4 million in Q4 2025 per WVE's latest filing, roughly flat from $8.4 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $8.4 million in Q3 2025 to a low of $3.8 million in Q1 2021.
  • Average Current Leases over 5 years is $6.2 million, with a median of $6.4 million recorded in 2023.
  • Peak YoY movement for Current Leases: soared 44.05% in 2023, then rose 9.47% in 2025.
  • A 5-year view of Current Leases shows it stood at $5.0 million in 2021, then grew by 10.78% to $5.5 million in 2022, then grew by 22.16% to $6.7 million in 2023, then increased by 13.76% to $7.6 million in 2024, then grew by 9.47% to $8.4 million in 2025.
  • Per Business Quant, the three most recent readings for WVE's Current Leases are $8.4 million (Q4 2025), $8.4 million (Q3 2025), and $8.1 million (Q2 2025).